A
Ana del Pozo-Rodríguez
Researcher at University of the Basque Country
Publications - 37
Citations - 1447
Ana del Pozo-Rodríguez is an academic researcher from University of the Basque Country. The author has contributed to research in topics: Gene delivery & Transfection. The author has an hindex of 19, co-authored 30 publications receiving 1130 citations.
Papers
More filters
Journal ArticleDOI
Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier
Ana Beloqui,María Ángeles Solinís,Alicia R. Gascón,Ana del Pozo-Rodríguez,Anne des Rieux,Véronique Préat +5 more
TL;DR: By modifying critical physicochemical parameters of the NLC formulation, this work was able to overcome the P-gp drug efflux and alter the transcytosis mechanism of the nanoparticles, which support the use of NLCs approaches for oral delivery of poorly water-soluble P- gp substrates.
Journal ArticleDOI
Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives
Itziar Gómez-Aguado,Julen Rodríguez-Castejón,Mónica Vicente-Pascual,Alicia Rodríguez-Gascón,María Ángeles Solinís,Ana del Pozo-Rodríguez +5 more
TL;DR: This manuscript includes a revision of the strategies employed to enhance in vitro transcribed mRNA functionality and efficacy, including the optimization of its stability and translational efficiency, as well as the regulation of its immunostimulatory properties.
Journal ArticleDOI
Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: The importance of the entry pathway
TL;DR: In spite of the high DNA condensation capacity of protamine and its content in NLS, this does not always lead to an improvement in cell transfection since it may impair some of the limiting steps of the transfections processes.
Journal ArticleDOI
A novel gene therapy vector based on hyaluronic acid and solid lipid nanoparticles for ocular diseases.
TL;DR: The therapeutic plasmid which encodes the protein Retinoschisin was employed achieving a positive transfection in ARPE-19 cells, showing a promising application of this new non-viral system for the treatment of X-linked juvenile retinoschisis by gene therapy.
Journal ArticleDOI
Lipid Nanoparticles as Drug/Gene Delivery Systems to the Retina
TL;DR: Scientific results are summarized that evidence the potential application of lipid nanoparticles as drug delivery systems for the retina and also as nonviral vectors in gene therapy of retina disorders, although much more effort is still needed before these lipidic systems could be available in the market.